ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00157209
Brief Title: Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)

First Submitted : September 8, 2005
First Submitted that Met QC Criteria : September 9, 2005
First Posted : September 12, 2005 (Estimate)

Results First Submitted : July 23, 2015
Results First Submitted that Met QC Criteria : October 19, 2015
Results First Posted : November 18, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : October 19, 2015
Last Update Posted : November 18, 2015 (Estimate)